Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor model.
Miyamoto R, Takigawa H, Yuge R, Shimizu D, Ariyoshi M, Otani R, Tsuboi A, Tanaka H, Yamashita K, Hiyama Y, Urabe Y, Ishikawa A, Sentani K, Oka S.
Miyamoto R, et al. Among authors: oka s.
Exp Mol Pathol. 2024 Jun;137:104896. doi: 10.1016/j.yexmp.2024.104896. Epub 2024 May 3.
Exp Mol Pathol. 2024.
PMID: 38703552
Free article.